Structures by: Türkmen H.
Total: 18
C25H21Br2N5Pd
C25H21Br2N5Pd
Dalton transactions (Cambridge, England : 2003) (2020) 49, 46 16903-16915
a=9.6188(11)Å b=11.9263(14)Å c=12.2365(13)Å
α=77.662(4)° β=71.146(5)° γ=69.041(4)°
C30H29ClN4Ru
C30H29ClN4Ru
Dalton transactions (Cambridge, England : 2003) (2020) 49, 46 16903-16915
a=9.6026(9)Å b=12.3020(13)Å c=13.6024(15)Å
α=100.477(5)° β=109.614(4)° γ=110.590(5)°
C20H17N4,C10H15Cl3Ir
C20H17N4,C10H15Cl3Ir
Dalton transactions (Cambridge, England : 2003) (2020) 49, 46 16903-16915
a=9.9976(9)Å b=11.8767(12)Å c=13.6237(14)Å
α=98.645(4)° β=96.039(5)° γ=110.163(4)°
3(C30H30ClN4Rh),CH2Cl2
3(C30H30ClN4Rh),CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 46 16903-16915
a=13.6235(10)Å b=15.9331(13)Å c=21.3560(18)Å
α=69.077(3)° β=83.636(4)° γ=88.592(3)°
C30H30ClIrN4
C30H30ClIrN4
Dalton transactions (Cambridge, England : 2003) (2020) 49, 46 16903-16915
a=13.700(3)Å b=15.904(4)Å c=21.409(6)Å
α=69.083(12)° β=83.451(12)° γ=88.890(13)°
C59H69Cl2N5Rh2,2(CH2Cl2)
C59H69Cl2N5Rh2,2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 48 17317-17328
a=26.8865(12)Å b=10.0794(4)Å c=23.4752(15)Å
α=90° β=110.681(6)° γ=90°
[μ-1,1-Bis(2,4,6-trimethylbenzyl)-3,3'-(2,3,5,6-tetramethyl-p- phenylenedibenzimidazole)-2,2'-diylidene]di-μ-bromo-disilver(I)
C46H50Ag2Br2N4
Acta Crystallographica Section E (2007) 63, 2 m619-m620
a=9.0005(5)Å b=15.8848(8)Å c=16.7023(10)Å
α=61.286(4)° β=78.137(5)° γ=83.419(5)°
Trans-[1,3-bis(2,4-dimethylphenyl) imidazolidin-2-ylidene]dichlorotriphenyl phosphinepalladium(II)
C37H37Cl2N2PPd
Acta Crystallographica Section C (2004) 60, 6 m254-m255
a=13.9423(6)Å b=14.7120(8)Å c=17.2894(7)Å
α=90.00° β=105.446(3)° γ=90.00°
Trans-[1,3-Bis(2,4,6-trimethylphenyl)imidazolidin-2- ylidene]dichlorido(triphenylphosphine-κP)palladium(II)
C39H41Cl2N2PPd
Acta Crystallographica Section C (2007) 63, 6 m277-m279
a=17.418(3)Å b=13.8020(17)Å c=14.982(6)Å
α=90.00° β=91.90(5)° γ=90.00°
3-Chloro-<i>N</i>-(4-sulfamoylphenyl)propanamide
C9H11ClN2O3S
Acta Crystallographica Section E (2010) 66, 7 o1559-o1560
a=7.7554(4)Å b=14.8191(8)Å c=9.7482(5)Å
α=90° β=94.181(4)° γ=90°
2-Chloro-<i>N</i>-(4-sulfamoylphenyl)acetamide
C8H9ClN2O3S
Acta Crystallographica Section E (2010) 66, 7 o1596
a=4.7870(2)Å b=14.1868(9)Å c=16.0158(9)Å
α=90° β=90.907(4)° γ=90°
4-(3-Chloro-2,2-dimethylpropanamido)benzenesulfonamide
C11H15ClN2O3S
Acta Crystallographica Section E (2012) 68, 12 o3430
a=20.4359(11)Å b=7.2437(4)Å c=9.4693(5)Å
α=90° β=98.222(3)° γ=90°
4-(5-Chloropentanamido)benzenesulfonamide
C11H15ClN2O3S
Acta Crystallographica Section E (2012) 68, 12 o3475-o3476
a=8.48720(10)Å b=8.7730(2)Å c=10.4572(3)Å
α=73.711(4)° β=85.281(4)° γ=63.393(3)°
4-{[4-(Dimethylamino)benzylidene]amino}benzenesulfonamide
C15H17N3O2S
Acta Crystallographica Section E (2014) 70, 6 o726-o727
a=16.8982(5)Å b=9.0273(3)Å c=9.8405(3)Å
α=90.00° β=101.552(3)° γ=90.00°
4-[3-(4-Methylpiperidin-1-yl)propanamido]benzenesulfonamide monohydrate
C15H23N3O3S,H2O
Acta Crystallographica Section E (2012) 68, 12 o3481
a=11.3200(3)Å b=7.4068(3)Å c=20.7937(8)Å
α=90° β=96.787(2)° γ=90°
C22H30BrIrN2
C22H30BrIrN2
Organometallics (2008) 27, 4 571
a=10.364(2)Å b=13.438(3)Å c=14.932(3)Å
α=90.00° β=96.208(4)° γ=90.00°
C22H30BrN2Rh
C22H30BrN2Rh
Organometallics (2008) 27, 4 571
a=10.3387(17)Å b=13.433(2)Å c=14.932(3)Å
α=90.00° β=96.477(3)° γ=90.00°
C27H40BrIrN2
C27H40BrIrN2
Organometallics (2008) 27, 4 571
a=17.867(2)Å b=8.7314(10)Å c=15.9881(19)Å
α=90.00° β=96.694(2)° γ=90.00°